• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    26 Stocks Moving in Monday's Pre-Market Session

    4/25/22 6:13:00 AM ET
    $AIM
    $ARDX
    $BRQS
    $CANG
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AIM alert in real time by email

    Gainers

    • ERYTECH Pharma S.A. (NASDAQ:ERYP) shares rose 88.4% to $2.30 in pre-market trading. Erytech Pharma recently announced publication of results from Eryapasse Phase 2 trial as treatment for hypersensitive ALL in the British Journal of Haematology.
    • Cango Inc. (NYSE:CANG) rose 23.7% to $2.92 in pre-market trading. Cango, last month, reported worse-than-expected Q4 EPS and sales results.
    • Aclarion, Inc. (NASDAQ:ACON) rose 15.7% to $3.15 in pre-market trading. The company, on Friday, priced its IPO at $4.35 per share.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) rose 15% to $1.30 in pre-market trading. TC Biopharm recently registered the U.K. trademark CryoTC for its proprietary process for freezing and thawing its lead oncology product, OmnImmune.
    • AIM ImmunoTech Inc. (NYSE:AIM) rose 14.8% to $1.17 in pre-market trading. AIM ImmunoTech recently issued summary of Ampligen data.
    • Cenntro Electric Group Limited (NASDAQ:CENN) rose 14.1% to $1.94 in pre-market trading after gaining around 7% on Friday.
    • Quantum Computing, Inc. (NASDAQ:QUBT) rose 11.8% to $1.99 in pre-market trading after declining around 5% on Friday.
    • Silicon Motion Technology Corporation (NASDAQ:SIMO) rose 9% to $84.00 in pre-market trading after Bloomberg reported that the company exploring a potential sale amid takeover interest.
    • Shift Technologies, Inc. (NASDAQ:SFT) rose 9.1% to $1.68 in pre-market trading. Shift is expected to report its financial results for the first quarter 2022, on May 10, 2022.
    • XORTX Therapeutics Inc. (NASDAQ:XRTX) rose 8.9% to $1.96 in pre-market trading. XORTX Therapeutics, last month, announced the submission of a Patent Cooperation Treaty patent application seeking international patent protection for the patent entitled "Compositions and Methods for Enhancing Anti-Vi."
    • Genocea Biosciences, Inc. (NASDAQ:GNCA) rose 8.8% to $0.4550 in pre-market trading.
    • Zosano Pharma Corporation (NASDAQ:ZSAN) shares rose 7.2% to $2.38 in pre-market trading after declining around 7% on Friday.
    • New Concept Energy, Inc. (NYSE:GBR) rose 6.9% to $2.93 in pre-market trading.
    • Ardelyx, Inc. (NASDAQ:ARDX) rose 6.9% to $0.7998 in pre-market trading. Ardelyx recently amended its license agreement, initially executed in 2017, granting Kyowa Kirin exclusive rights to develop and commercialize Ardelyx's tenapanor for cardiorenal diseases, including hyperphosphatemia, in Japan.

    Don’t forget to check out our premarket coverage here .

    Losers

    • Cypress Environmental Partners, L.P. (NYSE:CELP) fell 27.5% to $0.4666 in pre-market trading after the company said an affiliate of Argonaut Private Equity has acquired 100% of Cypress’s senior secured debt from the seven existing lenders.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 15.4% to $1.92 in pre-market trading. Vallon Pharmaceuticals shares jumped more than 100% on Friday after the company announced a review of strategic alternatives.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) shares fell 13.7% to $1.55 in pre-market trading after dropping 22% on Friday. The company recently announced it will present new data on JATENZO at the Androgen Society 4th Annual Meeting.
    • KemPharm, Inc. (NASDAQ:KMPH) shares fell 13.3% to $4.10 in pre-market trading after jumping around 12% on Friday. The company recently doses first subject in Phase 1 clinical trial evaluating cardiovascular safety of serdexmethylphenidate.
    • Moving iMage Technologies, Inc. (NASDAQ:MITQ) fell 12.5% to $1.39 in pre-market trading. Moving iMage Technologies shares climbed 38% on Friday after the company and SNDBX announced a strategic partnership to bring the full theatre experience to the gaming and e-Sports market.
    • Forge Global Holdings, Inc. (NYSE:FRGE) fell 12.4% to $12.30 in pre-market trading after climbing 20% on Friday.
    • Cyngn Inc. (NASDAQ:CYN) fell 11.5% to $2.38 in pre-market trading after climbing around 27% on Friday. Cyngn recently announced the official launch of DriveMod Kit, a turnkey autonomous vehicle solution
    • Borqs Technologies, Inc. (NASDAQ:BRQS) fell 10.3% to $0.2960 in pre-market trading after dropping 8% on Friday.
    • Koninklijke Philips N.V. (NYSE:PHG) shares fell 9.7% to $27.39 in pre-market trading. Philips reported a first-quarter FY22 sales growth of 2.6% year-on-year to €3.9 billion.
    • Wheels Up Experience Inc. (NYSE:UP) fell 8.4% to $2.77 in pre-market trading. Wheels Up Experience is expected to release its Q1 financial results after the market closes on Thursday, May 12, 2022.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) fell 8.4% to $17.40 in pre-market trading. The company, on Friday, priced its IPO at $4 per share.
    • Taseko Mines Limited (NYSE:TGB) shares fell 8% to $1.85 in pre-market trading after dropping 5% on Friday.
    Get the next $AIM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIM
    $ARDX
    $BRQS
    $CANG

    CompanyDatePrice TargetRatingAnalyst
    Quantum Computing Inc.
    $QUBT
    4/20/2026$20.00Outperform
    Northland Capital
    Silicon Motion Technology Corporation
    $SIMO
    1/22/2026Outperform
    William Blair
    Quantum Computing Inc.
    $QUBT
    1/15/2026$22.00Buy
    Rosenblatt
    Ardelyx Inc.
    $ARDX
    1/9/2026Neutral → Overweight
    Piper Sandler
    Quantum Computing Inc.
    $QUBT
    12/17/2025$12.00Neutral
    Wedbush
    Koninklijke Philips N.V. NY Registry Shares
    $PHG
    12/17/2025Sector Perform
    RBC Capital Mkts
    Forge Global Holdings Inc.
    $FRGE
    12/12/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    Forge Global Holdings Inc.
    $FRGE
    11/7/2025Overweight → Neutral
    Piper Sandler
    More analyst ratings

    $AIM
    $ARDX
    $BRQS
    $CANG
    SEC Filings

    View All

    SEC Form DEFA14A filed by Wheels Up Experience Inc.

    DEFA14A - Wheels Up Experience Inc. (0001819516) (Filer)

    4/24/26 7:07:27 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    SEC Form DEF 14A filed by Wheels Up Experience Inc.

    DEF 14A - Wheels Up Experience Inc. (0001819516) (Filer)

    4/24/26 7:05:29 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Wheels Up Experience Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Wheels Up Experience Inc. (0001819516) (Filer)

    4/24/26 6:56:02 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    $AIM
    $ARDX
    $BRQS
    $CANG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mott David M bought $1,946,331 worth of shares (333,333 units at $5.84), increasing direct ownership by 11% to 3,302,918 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    2/23/26 9:01:11 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Nevin James bought $44,168 worth of shares (1,950 units at $22.65), increasing direct ownership by 9% to 24,124 units (SEC Form 4)

    4 - Forge Global Holdings, Inc. (0001827821) (Issuer)

    8/7/25 4:55:46 PM ET
    $FRGE
    Investment Bankers/Brokers/Service
    Finance

    Director Mott David M bought $725,880 worth of shares (200,000 units at $3.63), increasing direct ownership by 7% to 2,896,871 units (SEC Form 4)

    4 - ARDELYX, INC. (0001437402) (Issuer)

    6/18/25 9:28:07 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIM
    $ARDX
    $BRQS
    $CANG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Quantum Computing with a new price target

    Northland Capital initiated coverage of Quantum Computing with a rating of Outperform and set a new price target of $20.00

    4/20/26 8:28:07 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    William Blair initiated coverage on Silicon Motion

    William Blair initiated coverage of Silicon Motion with a rating of Outperform

    1/22/26 8:30:26 AM ET
    $SIMO
    Semiconductors
    Technology

    Rosenblatt initiated coverage on Quantum Computing with a new price target

    Rosenblatt initiated coverage of Quantum Computing with a rating of Buy and set a new price target of $22.00

    1/15/26 8:40:11 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    $AIM
    $ARDX
    $BRQS
    $CANG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Silicon Motion Confirms Quarterly Dividend

    TAIPEI, Taiwan and MILPITAS, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (NASDAQ:SIMO)("Silicon Motion" or the "Company"), a global leader in designing and marketing NAND flash controllers for solid state storage devices, confirms today its quarterly cash dividend. On October 27, 2025, the Board of Directors of the Company declared payment of an annual dividend of US$2.00 per ADS1, equivalent to US$0.50 per ordinary share, which will be paid in four quarterly installments of $0.50 per ADS, equivalent to US$0.125 per ordinary share. According to the previously announced record and payment dates, the next quarterly installment will be paid on May 21, 202

    4/24/26 8:00:00 AM ET
    $SIMO
    Semiconductors
    Technology

    Wheels Up Announces Changes to Board of Directors

    Delta CFO Erik Snell to Join the Board, Replacing Delta COO Dan JankiTimothy Armstrong to Retire from the Board at the 2026 Annual Meeting of Stockholders and Roger Farah Expected to be Nominated for ElectionATLANTA, April 24, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP) ("Wheels Up" or the "Company") today announced that Erik Snell, Executive Vice President and Chief Financial Officer of Delta Air Lines, Inc. ("Delta") has been appointed to the Company's Board of Directors (the "Board") as a Delta designee, replacing Dan Janki, Executive Vice President and Chief Operating Officer of Delta. Mr. Snell previously served on the Board from July 2021 to September 2023.

    4/24/26 6:55:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

    April 23, 2026   Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in <0.5% of lead extraction procedures [1] but require immediate intervention Bridge Plus allows for rapid response when every second counts by deploying in under two minutes [2] and stopping up to 90% blood loss [3], helping stabilize patients with 30 minutes of hemostasis [4]Bridge Plus was built upon proven Bridge Occlusion Balloon technology, used in more than 50,000 U.S. procedures [5,*], with evidence showing improved survival when staged in advance [6,**] Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a globa

    4/23/26 9:00:00 AM ET
    $PHG
    Medical Electronics
    Health Care

    $AIM
    $ARDX
    $BRQS
    $CANG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Ettenberg Felecia

    3 - ARDELYX, INC. (0001437402) (Issuer)

    4/22/26 4:04:27 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Raab Michael

    4 - ARDELYX, INC. (0001437402) (Issuer)

    4/17/26 4:04:27 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Weimer Carl Scott

    4 - Quantum Computing Inc. (0001758009) (Issuer)

    4/14/26 6:23:33 PM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    $AIM
    $ARDX
    $BRQS
    $CANG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIM
    $ARDX
    $BRQS
    $CANG
    Leadership Updates

    Live Leadership Updates

    View All

    Wheels Up Announces Changes to Board of Directors

    Delta CFO Erik Snell to Join the Board, Replacing Delta COO Dan JankiTimothy Armstrong to Retire from the Board at the 2026 Annual Meeting of Stockholders and Roger Farah Expected to be Nominated for ElectionATLANTA, April 24, 2026 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP) ("Wheels Up" or the "Company") today announced that Erik Snell, Executive Vice President and Chief Financial Officer of Delta Air Lines, Inc. ("Delta") has been appointed to the Company's Board of Directors (the "Board") as a Delta designee, replacing Dan Janki, Executive Vice President and Chief Operating Officer of Delta. Mr. Snell previously served on the Board from July 2021 to September 2023.

    4/24/26 6:55:00 AM ET
    $UP
    Transportation Services
    Consumer Discretionary

    Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

    WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Felecia W. Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer (CLO). She will oversee Ardelyx's legal, compliance, regulatory, and government affairs operations. Ms. Ettenberg succeeds Elizabeth Grammer, who has chosen to retire after an extraordinary 16-year career at the company. "I am thrilled to welcome Felecia as our new Chief Legal Officer," said Mik

    4/20/26 8:00:00 AM ET
    $ARDX
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

    WALTHAM, Mass., April 01, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Rajani Dinavahi, MD, as Chief Medical Officer (CMO). Dr. Dinavahi brings more than two decades of experience in healthcare and biotechnology, spanning multiple therapeutic areas and modalities. She has extensive experience across immuno-oncology, autoimmune diseases, metabolic disease, nephrology and transplantation, with a track record of advancing programs from early development through Phase 3 and regulatory approval. Dr. Dinavahi m

    4/1/26 8:01:00 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIM
    $ARDX
    $BRQS
    $CANG
    Financials

    Live finance-specific insights

    View All

    Silicon Motion Confirms Quarterly Dividend

    TAIPEI, Taiwan and MILPITAS, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (NASDAQ:SIMO)("Silicon Motion" or the "Company"), a global leader in designing and marketing NAND flash controllers for solid state storage devices, confirms today its quarterly cash dividend. On October 27, 2025, the Board of Directors of the Company declared payment of an annual dividend of US$2.00 per ADS1, equivalent to US$0.50 per ordinary share, which will be paid in four quarterly installments of $0.50 per ADS, equivalent to US$0.125 per ordinary share. According to the previously announced record and payment dates, the next quarterly installment will be paid on May 21, 202

    4/24/26 8:00:00 AM ET
    $SIMO
    Semiconductors
    Technology

    Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026

    WALTHAM, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX) ("Ardelyx" or the "Company"), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced that management will host a webcast and conference call on Thursday, April 30, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the first quarter of 2026. Webcast InformationA live webcast of the conference call and accompanying slides will be available in the "Events and Presentations" section under "News and Events" within the Investors section of the Company'

    4/16/26 8:01:00 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Silicon Motion Announces First Quarter 2026 Earnings Conference Call

    TAIPEI, Taiwan and MILPITAS, Calif., April 10, 2026 (GLOBE NEWSWIRE) -- Silicon Motion Technology Corporation (NASDAQ:SIMO) ("Silicon Motion" or the "Company"), a global leader in NAND flash controllers for solid state storage devices, plans to release its first quarter 2026 financial results after the market closes on April 28, 2026 and will host a conference call on April 29 at 8:00 a.m. Eastern Time. Participants must pre-register using the link below to participate in the live call. CONFERENCE CALL DETAILS: Participants must register in advance to join the conference call using the link provided below. Conference access information (including dial-in information and a unique access

    4/10/26 8:00:00 AM ET
    $SIMO
    Semiconductors
    Technology

    $AIM
    $ARDX
    $BRQS
    $CANG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by AIM ImmunoTech Inc.

    SC 13D/A - AIM ImmunoTech Inc. (0000946644) (Subject)

    12/17/24 4:11:23 PM ET
    $AIM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by TC BioPharm (Holdings) plc

    SC 13G/A - TC BioPharm (Holdings) plc (0001872812) (Subject)

    11/14/24 4:41:42 PM ET
    $TCBP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Wheels Up Experience Inc.

    SC 13D/A - Wheels Up Experience Inc. (0001819516) (Subject)

    11/14/24 4:30:05 PM ET
    $UP
    Transportation Services
    Consumer Discretionary